DIAGNOS AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months

NEXT STORY
Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate
PREV STORY
India Plant Extract Market Analysis, 2018-2019 & 2023, Featuring Profiles on Dabur India, Emami, Patanjali, Arjuna Natural Extract Limited, Vidya Herbs, and More
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Interpace Diagnostics Announces CIGNA’s Expansion of Coverage to Now Include ThyraMIR®

National Plan Coverage for miRNA-based ClassifierPARSIPPANY, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- Interpace ...

author_avatar
NASDAQ Market News

Quipt Announces Execution of LOI to Acquire Leader in Comprehensive Respiratory Care Within the Long-Term Care Setting With Approximately $14 Million in Annualized Revenue and $1 Million in Net Income

author_avatar
NASDAQ Market News

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

Updated label may allow for increased dosing flexibility for patients with hyperkalemia (elevated blood ...

author_avatar
NASDAQ Market News